Why Canada Is The Future of Uranium Mining
Data centers are expanding at an unprecedented pace, driven by the need to build and train more AI models by the day. But here’s the shocking truth: AI-driven applications like ChatGPT consume
Vanguard S&P 500 Growth ETF: Leading the Charge in 2025
In the face of an evolving market landscape, investors are increasingly focusing on funds that offer growth potential, and one ETF that stands out is the Vanguard S&P 500 Growth ETF. This
Palantir’s 2024 Stock Surge: Should You Invest Now?
In 2024, Palantir Technologies has seen its stock price more than double, a remarkable run that has captured the attention of investors. Known for its cutting-edge work in artificial intelligence (AI), defense,
Moderna Reports Larger-Than-Expected Quarterly Loss
Biotech firm Moderna (MRNA.O) reported a bigger-than-expected quarterly loss, primarily due to charges related to scaling down manufacturing as demand for its COVID-19 vaccine weakens. The company posted a quarterly loss of
Super Micro Reports Strong Q2 Growth Amid AI Boom
Super Micro’s Revenue Surges on AI Demand Super Micro Computer Inc. (SMCI) posted impressive preliminary second-quarter fiscal 2025 results, with net sales reaching between $5.6 billion and $5.7 billion, a 54% year-over-year
Coca-Cola Posts Strong Q4 Growth, Plans Digital Expansion
Coca-Cola (KO) exceeded market expectations in its fourth-quarter earnings, reporting double-digit revenue growth, strategic market expansion, and continued investment in digital platforms. Q4 Performance: Strong Revenue and Margin Expansion Key Growth Drivers
Rivian Expands Van Sales Beyond Amazon to All U.S. Fleets
Rivian (RIVN) is now selling its electric delivery vans to fleets of all sizes across the U.S., the company announced Monday. This move comes more than a year after ending its exclusive
Eli Lilly’s Q4: Strong Drug Demand, But Sales Miss Target
Eli Lilly posted a mixed earnings report for the fourth quarter, with strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro driving revenue growth. However, sales slightly missed
PepsiCo Faces Sales Decline Amid Consumer Spending Shift
PepsiCo’s latest earnings report reveals a tough market environment as the snack and beverage giant struggles with weakening demand in the U.S., its largest market. The company missed quarterly revenue expectations and
Merck Shares Drop 10% After Weak 2025 Sales Forecast
Shares of Merck (MRK) fell sharply on Tuesday after the company issued a lower-than-expected 2025 sales forecast, citing a temporary pause in Gardasil vaccine shipments to China. The stock dropped 10% to
Microsoft Shares Drop Over 6% After Weak Guidance
Microsoft shares tumbled more than 6% on Thursday after issuing weaker-than-expected current-quarter guidance. The stock was on pace for its worst day in more than two years. The decline followed the company’s
Retail Investors Pour $900M Into Nvidia After AI Sell-Off
Retail investors have aggressively bought Nvidia (NVDA) shares this week, pouring in more than $900 million as they seized the opportunity to buy AI stocks at a discount following fears over China’s
ASML Crushes Q4 Expectations with 169% Surge in Bookings
ASML (NASDAQ: ASML) delivered a blowout earnings report, posting a 169% surge in Q4 net bookings to $7.09 billion—nearly double analyst predictions. Despite concerns surrounding Chinese AI startup DeepSeek, which recently shook
